spacer
The Healthcare Sales & Marketing Network celebrates 23 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  ALEVE 

 HSMN NewsFeed - 19 Oct 2017
Bayer Appoints Jennifer Brendel to Vice President, Head of U.S. Consumer Health Communications
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jul 2016
Bayer Announces the Launch of Aleve(R) Direct Therapy(TM) TENS Device to Help People who Suffer from Lower Back Pain
Devices Product Launch
 HSMN NewsFeed - 22 Feb 2011
Erica L. Mann, Former Pfizer Executive, Appointed New President of Bayer HealthCare's Global Consumer Care Division
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Aug 2007
FDA Issues Second Approvable Letter for Trexima(TM)
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Jun 2007
Trexima(TM) (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free Response Across Multiple Attacks
Biopharmaceuticals Neurology
 HSMN NewsFeed - 2 May 2007
Trexima(TM) (Sumatriptan/Naproxen Sodium) Demonstrated Efficacy Across Multiple Migraine Attacks
Biopharmaceuticals Neurology
 HSMN NewsFeed - 2 May 2007
Trexima(TM) (Sumatriptan/Naproxen Sodium) Provided Relief of Both Traditional and Non-traditional Migraine Symptoms
Biopharmaceuticals Neurology
 HSMN NewsFeed - 13 Mar 2007
Introducing New ALEVE(R) Liquid Gels
Biopharmaceuticals
 HSMN NewsFeed - 8 Jan 2007
Panacos Appoints Alan W. Dunton, M.D. as New CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Nov 2006
POZEN Submits Full Response to FDA Approvable Letter For Trexima(TM)
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Oct 2006
Targacept Announces Addition of Alan W. Dunton, M.D. to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Sep 2006
New Analysis Shows Patients Who Treat Their Migraine Pain Early With Trexima(TM) (Sumatriptan Succinate/Naproxen Sodium) Have Higher Sustained Pain-Free Rates Than Those Who Treat Late
Biopharmaceuticals
 HSMN NewsFeed - 20 Sep 2006
New Data Show Consistent Efficacy and Tolerability of Trexima(TM) (Sumatriptan Succinate/Naproxen Sodium) Across Multiple Migraine Attacks
Biopharmaceuticals
 HSMN NewsFeed - 20 Sep 2006
New Data Show Peak Concentration of Sumatriptan Occurred Earlier With Trexima(TM) (Sumatriptan Succinate/Naproxen Sodium) Compared to Imitrex(R) (Sumatriptan Succinate)
Biopharmaceuticals
 HSMN NewsFeed - 9 Jun 2006
POZEN Inc. and GlaxoSmithKline Report Receipt of Approvable Letter for Investigational Migraine Treatment
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 May 2006
New Stroke Guidelines Underscore Importance of Aspirin for Women
Biopharmaceuticals Neurology
 HSMN NewsFeed - 5 Apr 2006
New Data Presented on Satisfaction, Productivity and Long-Term Safety of a Single Tablet Containing Sumatriptan Formulated With RT Technology(TM) and Naproxen Sodium
Biopharmaceuticals Neurology
 HSMN NewsFeed - 5 Apr 2006
New Pivotal Trial Data Demonstrated Superior Clinical Benefits of Single Tablet Containing Sumatriptan Formulated With RT Technology(TM) and Naproxen Sodium
Biopharmaceuticals Neurology
 HSMN NewsFeed - 12 Mar 2006
Aspirin Unsurpassed in Prevention of Heart Attack and Stroke in Wide Range of Patients
Biopharmaceuticals Cardiology
Return to NewsFeed  

 Additional items found! 9

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 9 additional stories matching:
ALEVE
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.